B. Ulukol, F. Orhon, A. Hanoluk, and N. Akar, Serum Pro-Hepcidin Levels and Relationship with Ferritin in Healthy Non-Anaemic Infants, Acta Haematologica, vol.118, issue.2, pp.70-72, 2007.
DOI : 10.1159/000102606

A. Kato, T. Tsuji, J. Luo, Y. Sakao, and H. Yasuda, Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis Patients, American Journal of Nephrology, vol.28, issue.1, pp.115-121, 2008.
DOI : 10.1159/000109968

J. Malyszko, J. Malyszko, and M. Mysliwiec, A Possible Role of Hepcidin in the Pathogenesis of Anemia Among Kidney Allograft Recipients, Transplantation Proceedings, vol.41, issue.8, pp.3056-3065, 2009.
DOI : 10.1016/j.transproceed.2009.08.003

N. Tomosugi, H. Kawabata, R. Wakatabe, M. Higuchi, and H. Yamaya, Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System, Blood, vol.108, issue.4, pp.1381-1388, 2006.
DOI : 10.1182/blood-2005-10-4043

I. Theurl, E. Aigner, M. Theurl, M. Nairz, and M. Seifert, Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications, Blood, vol.113, issue.21, pp.5277-86, 2009.
DOI : 10.1182/blood-2008-12-195651

N. Grebenchtchikov, A. Geurts-moespot, J. Kroot, M. Den-heijer, and H. Tjalsma, High-sensitive radioimmunoassay for human serum hepcidin, British Journal of Haematology, vol.26, issue.3, 2009.
DOI : 10.1111/j.1365-2141.2009.07758.x

H. Li, M. Rose, L. Tran, J. Zhang, and L. Miranda, Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS, Journal of Pharmacological and Toxicological Methods, vol.59, issue.3, pp.171-80, 2009.
DOI : 10.1016/j.vascn.2009.02.004

D. Ashby, D. Gale, M. Busbridge, K. Murphy, and N. Duncan, Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease, Kidney International, vol.75, issue.9, pp.976-81, 2009.
DOI : 10.1038/ki.2009.21

J. Zaritsky, B. Young, B. Gales, H. Wang, and A. Rastogi, Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients, Clinical Journal of the American Society of Nephrology, vol.5, issue.6, pp.1010-1014, 2010.
DOI : 10.2215/CJN.08161109

J. Malyszko, J. Malyszko, and M. Mysliwiec, Hyporesponsiveness to Erythropoietin Therapy in Hemodialyzed Patients: Potential Role of Prohepcidin, Hepcidin, and Inflammation, Renal Failure, vol.55, issue.80, pp.544-552, 2009.
DOI : 10.1038/nm1629

E. Costa, D. Swinkels, C. Laarakkers, P. Rocha-pereira, and S. Rocha, Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients, Acta Haematologica, vol.122, issue.4, pp.226-235, 2009.
DOI : 10.1159/000253590

B. Ford, C. Eby, M. Scott, and D. Coyne, Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients, Kidney International, vol.78, issue.8, pp.769-73, 2010.
DOI : 10.1038/ki.2010.254

O. Moranne, M. Froissart, J. Rossert, C. Gauci, and J. Boffa, Timing of Onset of CKD-Related Metabolic Complications, Journal of the American Society of Nephrology, vol.20, issue.1, pp.164-71, 2009.
DOI : 10.1681/ASN.2008020159

URL : https://hal.archives-ouvertes.fr/inserm-00555033

L. Mercadal, M. Metzger, N. Casadevall, J. Haymann, and A. Karras, Timing and Determinants of Erythropoietin Deficiency in Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.7, issue.1, pp.35-42, 2012.
DOI : 10.2215/CJN.04690511

URL : https://hal.archives-ouvertes.fr/inserm-00739807

D. Lipschitz, J. Cook, and C. Finch, A Clinical Evaluation of Serum Ferritin as an Index of Iron Stores, New England Journal of Medicine, vol.290, issue.22, pp.443-451, 1992.
DOI : 10.1056/NEJM197405302902201

K. Hintze and J. Mcclung, Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia, Advances in Hematology, vol.137, issue.11, 2011.
DOI : 10.1007/s12011-010-8932-6

T. Galesloot, S. Vermeulen, A. Geurts-moespot, S. Klaver, and J. Kroot, Serum hepcidin: reference ranges and biochemical correlates in the general population, Blood, vol.117, issue.25, pp.218-243, 2011.
DOI : 10.1182/blood-2011-02-337907

N. Van-der-weerd, M. Grooteman, M. Bots, M. Van-den-dorpel, and C. Hoedt, Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents, PLoS ONE, vol.2010, issue.7, p.39783, 2012.
DOI : 10.1371/journal.pone.0039783.s002

L. Valenti, P. Messa, S. Pelusi, N. Campostrini, and D. Girelli, Hepcidin levels in chronic hemodialysis patients: a critical evaluation, Clinical Chemistry and Laboratory Medicine, vol.52, issue.5, pp.1-7, 2013.
DOI : 10.1515/cclm-2013-0769

S. Pelusi, D. Girelli, R. Rametta, N. Campostrini, and C. Alfieri, The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis, BMC Nephrology, vol.151, issue.Suppl 2, p.4, 2013.
DOI : 10.1111/j.1365-2141.2010.08349.x

S. Bekri, P. Gual, R. Anty, N. Luciani, and M. Dahman, Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH, Gastroenterology, vol.131, issue.3, pp.788-96, 2006.
DOI : 10.1053/j.gastro.2006.07.007

T. Bartnikas, N. Andrews, and M. Fleming, Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice, Blood, vol.117, issue.2, pp.630-637, 2011.
DOI : 10.1182/blood-2010-05-287359

K. Gkouvatsos, G. Papanikolaou, and K. Pantopoulos, Regulation of iron transport and the role of transferrin, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1820, issue.3, pp.188-202, 2012.
DOI : 10.1016/j.bbagen.2011.10.013

L. Mercadal, M. Metzger, J. Haymann, E. Thervet, and J. Boffa, NephroTest Study Group. A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia, PLoS One, vol.19, issue.92, p.84144, 2014.

J. Zaritsky, Y. B. Wang, H. Westerman, M. Olbina, and G. , Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.4, issue.6, pp.1051-1057, 2009.
DOI : 10.2215/CJN.05931108

H. Peters, C. Laarakkers, D. Swinkels, and J. Wetzels, Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate, Nephrology Dialysis Transplantation, vol.25, issue.3, pp.848-53, 2010.
DOI : 10.1093/ndt/gfp546

T. Uehata, N. Tomosugi, T. Shoji, Y. Sakaguchi, and A. Suzuki, Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study, Nephrology Dialysis Transplantation, vol.27, issue.3, pp.1076-83, 2012.
DOI : 10.1093/ndt/gfr431

E. Canavesi, C. Alfieri, S. Pelusi, and L. Valenti, Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease, World Journal of Nephrology, vol.1, issue.6, pp.166-176, 2012.
DOI : 10.5527/wjn.v1.i6.166

H. Peters, C. Laarakkers, P. Pickkers, R. Masereeuw, and O. Boerman, Tubular reabsorption and local production of urine hepcidin-25, BMC Nephrology, vol.35, issue.1, p.70, 2013.
DOI : 10.1016/j.bcmd.2005.06.002

A. Kim, E. Fung, S. Parikh, E. Valore, and V. Gabayan, A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin, Blood, vol.123, issue.8, pp.1129-1165, 2014.
DOI : 10.1182/blood-2013-08-521419